| Financial Year |
March 31 2023 |
| Monetary Funds |
2,753,033,313.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,361,838,470.48 |
| Advances to Suppliers |
64,445,066.98 |
| Other Receivables |
85,337,138.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
684,398,366.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,043,854.45 |
| Total Current Assets |
5,054,546,956.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
366,059,566.31 |
| Investment Properties |
4,524,206.64 |
| Fixed Assetes |
2,181,591,222.72 |
| Under-construction Projects |
1,066,170,013.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
264,477,900.88 |
| R&D expenses |
-- |
| Goodwill |
328,686,395.47 |
| Long-Term Deferred and Prepaid Expenses |
158,709,442.45 |
| Deferred Income Tax Assets |
72,938,284.20 |
| Other Non-Current Assets |
91,429,255.37 |
| Sub-Total of Non-Current Assets |
4,969,188,661.12 |
| Total Assets |
10,023,735,617.15 |
| Short-Term Loans |
213,357,792.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
772,274,509.40 |
| Accounts Payable |
446,843,253.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
265,068,624.68 |
| Taxes Payable |
168,036,836.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
145,607,431.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
157,950,447.10 |
| Other Current Liabilities |
6,111,187.53 |
| Sub-Total of Current Liabilities |
2,329,443,014.46 |
| Long-term Loans |
395,226,561.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
74,084,487.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
911,552,118.09 |
| Total Liabilities |
3,240,995,132.55 |
| Paid-In Capital(Or Share Stock) |
545,955,020.00 |
| Capital Surplus |
1,970,728,837.81 |
| Surplus Reserve |
273,013,710.00 |
| LESS:Treasury Stock |
130,887,050.64 |
| Undistributed Profits |
3,659,218,439.30 |
| Minority Stockholder's Interest |
445,450,220.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,337,290,264.09 |
| Owner's Equity（Stockholder's Equity） |
6,782,740,484.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,023,735,617.15 |
